Global Cancer/Tumor Profiling Market Size, Share, Growth Analysis Report - Forecast 2034
Cancer/Tumor Profiling Market By Technology (Immunoassays, Next-Generation Sequencing, Polymerase Chain Reaction, Mass Spectrometry, In-Situ Hybridization, Microarrays, and Others), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, and Others), Biomarker Type (Genomic Biomarker, Protein Biomarker, and Others), Application (Research and Clinical), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
Category: Pharmaceutical Report Format : PDF
Pages: 245 Report Code: ZMR-1160
Published Date: Mar-2025 Status : Published
| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 9.86 Billion | USD 26.18 Billion | 10.4% | 2024 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Cancer/Tumor Profiling Market, (2022 - 2030) (USD Billion)
- 2.2 Global Cancer/Tumor Profiling Market : snapshot
- Chapter 3. Global Cancer/Tumor Profiling Market - Industry Analysis
- 3.1 Cancer/Tumor Profiling Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Increased cancer incidence and improvements in tumor profiling technology to drive the market growth
- 3.3 Market Restraints
- 3.3.1. Collection and storage issues
- 3.4 Market Opportunities
- 3.4.1. Increasing preference for personalized medicine
- 3.5 Market Challenges
- 3.5.1. Low biomarker discovery-to-approval ratio
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Technology
- 3.7.2 Market attractiveness analysis By Cancer Type
- 3.7.3 Market attractiveness analysis By Biomarker Type
- 3.7.4 Market attractiveness analysis By Application
- Chapter 4. Global Cancer/Tumor Profiling Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Cancer/Tumor Profiling Market: company market share, 2021
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Cancer/Tumor Profiling Market - Technology Analysis
- 5.1 Global Cancer/Tumor Profiling Market overview: By Technology
- 5.1.1 Global Cancer/Tumor Profiling Market share, By Technology, 2021 and 2030
- 5.2 Immunoassays
- 5.2.1 Global Cancer/Tumor Profiling Market by Immunoassays, 2022 - 2030 (USD Billion)
- 5.3 Next-Generation Sequencing
- 5.3.1 Global Cancer/Tumor Profiling Market by Next-Generation Sequencing, 2022 - 2030 (USD Billion)
- 5.4 Polymerase Chain Reaction
- 5.4.1 Global Cancer/Tumor Profiling Market by Polymerase Chain Reaction, 2022 - 2030 (USD Billion)
- 5.5 Mass Spectrometry
- 5.5.1 Global Cancer/Tumor Profiling Market by Mass Spectrometry, 2022 - 2030 (USD Billion)
- 5.6 In-Situ Hybridization
- 5.6.1 Global Cancer/Tumor Profiling Market by In-Situ Hybridization, 2022 - 2030 (USD Billion)
- 5.7 Microarrays
- 5.7.1 Global Cancer/Tumor Profiling Market by Microarrays, 2022 - 2030 (USD Billion)
- 5.8 Others
- 5.8.1 Global Cancer/Tumor Profiling Market by Others, 2022 - 2030 (USD Billion)
- 5.1 Global Cancer/Tumor Profiling Market overview: By Technology
- Chapter 6. Global Cancer/Tumor Profiling Market - Cancer Type Analysis
- 6.1 Global Cancer/Tumor Profiling Market overview: By Cancer Type
- 6.1.1 Global Cancer/Tumor Profiling Market share, By Cancer Type, 2021 and 2030
- 6.2 Breast Cancer
- 6.2.1 Global Cancer/Tumor Profiling Market by Breast Cancer, 2022 - 2030 (USD Billion)
- 6.3 Lung Cancer
- 6.3.1 Global Cancer/Tumor Profiling Market by Lung Cancer, 2022 - 2030 (USD Billion)
- 6.4 Colorectal Cancer
- 6.4.1 Global Cancer/Tumor Profiling Market by Colorectal Cancer, 2022 - 2030 (USD Billion)
- 6.5 Prostate Cancer
- 6.5.1 Global Cancer/Tumor Profiling Market by Prostate Cancer, 2022 - 2030 (USD Billion)
- 6.6 Melanoma Cancer
- 6.6.1 Global Cancer/Tumor Profiling Market by Melanoma Cancer, 2022 - 2030 (USD Billion)
- 6.7 Others
- 6.7.1 Global Cancer/Tumor Profiling Market by Others, 2022 - 2030 (USD Billion)
- 6.1 Global Cancer/Tumor Profiling Market overview: By Cancer Type
- Chapter 7. Global Cancer/Tumor Profiling Market - Biomarker Type Analysis
- 7.1 Global Cancer/Tumor Profiling Market overview: By Biomarker Type
- 7.1.1 Global Cancer/Tumor Profiling Market share, By Biomarker Type, 2021 and 2030
- 7.2 Genomic Biomarker
- 7.2.1 Global Cancer/Tumor Profiling Market by Genomic Biomarker, 2022 - 2030 (USD Billion)
- 7.3 Protein Biomarker
- 7.3.1 Global Cancer/Tumor Profiling Market by Protein Biomarker, 2022 - 2030 (USD Billion)
- 7.4 Others
- 7.4.1 Global Cancer/Tumor Profiling Market by Others, 2022 - 2030 (USD Billion)
- 7.1 Global Cancer/Tumor Profiling Market overview: By Biomarker Type
- Chapter 8. Global Cancer/Tumor Profiling Market - Application Analysis
- 8.1 Global Cancer/Tumor Profiling Market overview: By Application
- 8.1.1 Global Cancer/Tumor Profiling Market share, By Application, 2021 and 2030
- 8.2 Research
- 8.2.1 Global Cancer/Tumor Profiling Market by Research, 2022 - 2030 (USD Billion)
- 8.3 Clinical
- 8.3.1 Global Cancer/Tumor Profiling Market by Clinical, 2022 - 2030 (USD Billion)
- 8.1 Global Cancer/Tumor Profiling Market overview: By Application
- Chapter 9. Cancer/Tumor Profiling Market - Regional Analysis
- 9.1 Global Cancer/Tumor Profiling Market Regional Overview
- 9.2 Global Cancer/Tumor Profiling Market Share, by Region, 2021 & 2030 (USD Billion)
- 9.3. North America
- 9.3.1 North America Cancer/Tumor Profiling Market, 2022 - 2030 (USD Billion)
- 9.3.1.1 North America Cancer/Tumor Profiling Market, by Country, 2022 - 2030 (USD Billion)
- 9.3.1 North America Cancer/Tumor Profiling Market, 2022 - 2030 (USD Billion)
- 9.4 North America Cancer/Tumor Profiling Market, by Technology, 2022 - 2030
- 9.4.1 North America Cancer/Tumor Profiling Market, by Technology, 2022 - 2030 (USD Billion)
- 9.5 North America Cancer/Tumor Profiling Market, by Cancer Type, 2022 - 2030
- 9.5.1 North America Cancer/Tumor Profiling Market, by Cancer Type, 2022 - 2030 (USD Billion)
- 9.6 North America Cancer/Tumor Profiling Market, by Biomarker Type, 2022 - 2030
- 9.6.1 North America Cancer/Tumor Profiling Market, by Biomarker Type, 2022 - 2030 (USD Billion)
- 9.7 North America Cancer/Tumor Profiling Market, by Application, 2022 - 2030
- 9.7.1 North America Cancer/Tumor Profiling Market, by Application, 2022 - 2030 (USD Billion)
- 9.4. Europe
- 9.4.2 Europe Cancer/Tumor Profiling Market, 2022 - 2030 (USD Billion)
- 9.4.2.1 Europe Cancer/Tumor Profiling Market, by Country, 2022 - 2030 (USD Billion)
- 9.4.2 Europe Cancer/Tumor Profiling Market, 2022 - 2030 (USD Billion)
- 9.4 Europe Cancer/Tumor Profiling Market, by Technology, 2022 - 2030
- 9.4.1 Europe Cancer/Tumor Profiling Market, by Technology, 2022 - 2030 (USD Billion)
- 9.5 Europe Cancer/Tumor Profiling Market, by Cancer Type, 2022 - 2030
- 9.5.1 Europe Cancer/Tumor Profiling Market, by Cancer Type, 2022 - 2030 (USD Billion)
- 9.6 Europe Cancer/Tumor Profiling Market, by Biomarker Type, 2022 - 2030
- 9.6.1 Europe Cancer/Tumor Profiling Market, by Biomarker Type, 2022 - 2030 (USD Billion)
- 9.7 Europe Cancer/Tumor Profiling Market, by Application, 2022 - 2030
- 9.7.1 Europe Cancer/Tumor Profiling Market, by Application, 2022 - 2030 (USD Billion)
- 9.5. Asia Pacific
- 9.5.3 Asia Pacific Cancer/Tumor Profiling Market, 2022 - 2030 (USD Billion)
- 9.5.3.1 Asia Pacific Cancer/Tumor Profiling Market, by Country, 2022 - 2030 (USD Billion)
- 9.5.3 Asia Pacific Cancer/Tumor Profiling Market, 2022 - 2030 (USD Billion)
- 9.4 Asia Pacific Cancer/Tumor Profiling Market, by Technology, 2022 - 2030
- 9.4.1 Asia Pacific Cancer/Tumor Profiling Market, by Technology, 2022 - 2030 (USD Billion)
- 9.5 Asia Pacific Cancer/Tumor Profiling Market, by Cancer Type, 2022 - 2030
- 9.5.1 Asia Pacific Cancer/Tumor Profiling Market, by Cancer Type, 2022 - 2030 (USD Billion)
- 9.6 Asia Pacific Cancer/Tumor Profiling Market, by Biomarker Type, 2022 - 2030
- 9.6.1 Asia Pacific Cancer/Tumor Profiling Market, by Biomarker Type, 2022 - 2030 (USD Billion)
- 9.7 Asia Pacific Cancer/Tumor Profiling Market, by Application, 2022 - 2030
- 9.7.1 Asia Pacific Cancer/Tumor Profiling Market, by Application, 2022 - 2030 (USD Billion)
- 9.6. Latin America
- 9.6.4 Latin America Cancer/Tumor Profiling Market, 2022 - 2030 (USD Billion)
- 9.6.4.1 Latin America Cancer/Tumor Profiling Market, by Country, 2022 - 2030 (USD Billion)
- 9.6.4 Latin America Cancer/Tumor Profiling Market, 2022 - 2030 (USD Billion)
- 9.4 Latin America Cancer/Tumor Profiling Market, by Technology, 2022 - 2030
- 9.4.1 Latin America Cancer/Tumor Profiling Market, by Technology, 2022 - 2030 (USD Billion)
- 9.5 Latin America Cancer/Tumor Profiling Market, by Cancer Type, 2022 - 2030
- 9.5.1 Latin America Cancer/Tumor Profiling Market, by Cancer Type, 2022 - 2030 (USD Billion)
- 9.6 Latin America Cancer/Tumor Profiling Market, by Biomarker Type, 2022 - 2030
- 9.6.1 Latin America Cancer/Tumor Profiling Market, by Biomarker Type, 2022 - 2030 (USD Billion)
- 9.7 Latin America Cancer/Tumor Profiling Market, by Application, 2022 - 2030
- 9.7.1 Latin America Cancer/Tumor Profiling Market, by Application, 2022 - 2030 (USD Billion)
- 9.7. The Middle-East and Africa
- 9.7.5 The Middle-East and Africa Cancer/Tumor Profiling Market, 2022 - 2030 (USD Billion)
- 9.7.5.1 The Middle-East and Africa Cancer/Tumor Profiling Market, by Country, 2022 - 2030 (USD Billion)
- 9.7.5 The Middle-East and Africa Cancer/Tumor Profiling Market, 2022 - 2030 (USD Billion)
- 9.4 The Middle-East and Africa Cancer/Tumor Profiling Market, by Technology, 2022 - 2030
- 9.4.1 The Middle-East and Africa Cancer/Tumor Profiling Market, by Technology, 2022 - 2030 (USD Billion)
- 9.5 The Middle-East and Africa Cancer/Tumor Profiling Market, by Cancer Type, 2022 - 2030
- 9.5.1 The Middle-East and Africa Cancer/Tumor Profiling Market, by Cancer Type, 2022 - 2030 (USD Billion)
- 9.6 The Middle-East and Africa Cancer/Tumor Profiling Market, by Biomarker Type, 2022 - 2030
- 9.6.1 The Middle-East and Africa Cancer/Tumor Profiling Market, by Biomarker Type, 2022 - 2030 (USD Billion)
- 9.7 The Middle-East and Africa Cancer/Tumor Profiling Market, by Application, 2022 - 2030
- 9.7.1 The Middle-East and Africa Cancer/Tumor Profiling Market, by Application, 2022 - 2030 (USD Billion)
- Chapter 10. Company Profiles
- 10.1 QIAGEN
- 10.1.1 Overview
- 10.1.2 Financials
- 10.1.3 Product Portfolio
- 10.1.4 Business Strategy
- 10.1.5 Recent Developments
- 10.2 Illumina Inc.
- 10.2.1 Overview
- 10.2.2 Financials
- 10.2.3 Product Portfolio
- 10.2.4 Business Strategy
- 10.2.5 Recent Developments
- 10.3 NeoGenomics Laboratories Inc.
- 10.3.1 Overview
- 10.3.2 Financials
- 10.3.3 Product Portfolio
- 10.3.4 Business Strategy
- 10.3.5 Recent Developments
- 10.4 Genomic Health Inc.
- 10.4.1 Overview
- 10.4.2 Financials
- 10.4.3 Product Portfolio
- 10.4.4 Business Strategy
- 10.4.5 Recent Developments
- 10.5 HTG Molecular Diagnostics Inc.
- 10.5.1 Overview
- 10.5.2 Financials
- 10.5.3 Product Portfolio
- 10.5.4 Business Strategy
- 10.5.5 Recent Developments
- 10.6 Caris Life Sciences
- 10.6.1 Overview
- 10.6.2 Financials
- 10.6.3 Product Portfolio
- 10.6.4 Business Strategy
- 10.6.5 Recent Developments
- 10.7 Helomics Corporation
- 10.7.1 Overview
- 10.7.2 Financials
- 10.7.3 Product Portfolio
- 10.7.4 Business Strategy
- 10.7.5 Recent Developments
- 10.8 NanoString Technologies Inc.
- 10.8.1 Overview
- 10.8.2 Financials
- 10.8.3 Product Portfolio
- 10.8.4 Business Strategy
- 10.8.5 Recent Developments
- 10.9 Sysmex Corporation
- 10.9.1 Overview
- 10.9.2 Financials
- 10.9.3 Product Portfolio
- 10.9.4 Business Strategy
- 10.9.5 Recent Developments
- 10.10 Ribomed Biotechnologies Inc.
- 10.10.1 Overview
- 10.10.2 Financials
- 10.10.3 Product Portfolio
- 10.10.4 Business Strategy
- 10.10.5 Recent Developments
- 10.11 Guardant Health Inc.
- 10.11.1 Overview
- 10.11.2 Financials
- 10.11.3 Product Portfolio
- 10.11.4 Business Strategy
- 10.11.5 Recent Developments
- 10.12 Foundation Medicine
- 10.12.1 Overview
- 10.12.2 Financials
- 10.12.3 Product Portfolio
- 10.12.4 Business Strategy
- 10.12.5 Recent Developments
- 10.13 Roche Diagnostics
- 10.13.1 Overview
- 10.13.2 Financials
- 10.13.3 Product Portfolio
- 10.13.4 Business Strategy
- 10.13.5 Recent Developments
- 10.14 GenScript Biotech Corporation
- 10.14.1 Overview
- 10.14.2 Financials
- 10.14.3 Product Portfolio
- 10.14.4 Business Strategy
- 10.14.5 Recent Developments
- 10.15 Tempus Labs
- 10.15.1 Overview
- 10.15.2 Financials
- 10.15.3 Product Portfolio
- 10.15.4 Business Strategy
- 10.15.5 Recent Developments
- 10.16 Boreal Genomics Inc
- 10.16.1 Overview
- 10.16.2 Financials
- 10.16.3 Product Portfolio
- 10.16.4 Business Strategy
- 10.16.5 Recent Developments
- 10.17 Perthera
- 10.17.1 Overview
- 10.17.2 Financials
- 10.17.3 Product Portfolio
- 10.17.4 Business Strategy
- 10.17.5 Recent Developments
- 10.18 Agendia
- 10.18.1 Overview
- 10.18.2 Financials
- 10.18.3 Product Portfolio
- 10.18.4 Business Strategy
- 10.18.5 Recent Developments
- 10.19 Omniseq
- 10.19.1 Overview
- 10.19.2 Financials
- 10.19.3 Product Portfolio
- 10.19.4 Business Strategy
- 10.19.5 Recent Developments
- 10.20 Histogene X
- 10.20.1 Overview
- 10.20.2 Financials
- 10.20.3 Product Portfolio
- 10.20.4 Business Strategy
- 10.20.5 Recent Developments
- 10.1 QIAGEN
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Cancer/Tumor Profiling Market, 2022 - 2030 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global Cancer/Tumor Profiling Market attractiveness, By Technology
- 6. Global Cancer/Tumor Profiling Market attractiveness, By Cancer Type
- 7. Global Cancer/Tumor Profiling Market attractiveness, By Biomarker Type
- 8. Global Cancer/Tumor Profiling Market attractiveness, By Application
- 9. Global Cancer/Tumor Profiling Market share by Technology, 2022 and 2030 (USD Billion)
- 10. Global Cancer/Tumor Profiling Market by Immunoassays, 2022 - 2030 (USD Billion)
- 11. Global Cancer/Tumor Profiling Market by Next-Generation Sequencing, 2022 - 2030 (USD Billion)
- 12. Global Cancer/Tumor Profiling Market by Polymerase Chain Reaction, 2022 - 2030 (USD Billion)
- 13. Global Cancer/Tumor Profiling Market by Mass Spectrometry, 2022 - 2030 (USD Billion)
- 14. Global Cancer/Tumor Profiling Market by In-Situ Hybridization, 2022 - 2030 (USD Billion)
- 15. Global Cancer/Tumor Profiling Market by Microarrays, 2022 - 2030 (USD Billion)
- 16. Global Cancer/Tumor Profiling Market by Others, 2022 - 2030 (USD Billion)
- 17. Global Cancer/Tumor Profiling Market share by Cancer Type, 2022 and 2030 (USD Billion)
- 18. Global Cancer/Tumor Profiling Market by Breast Cancer, 2022 - 2030 (USD Billion)
- 19. Global Cancer/Tumor Profiling Market by Lung Cancer, 2022 - 2030 (USD Billion)
- 20. Global Cancer/Tumor Profiling Market by Colorectal Cancer, 2022 - 2030 (USD Billion)
- 21. Global Cancer/Tumor Profiling Market by Prostate Cancer, 2022 - 2030 (USD Billion)
- 22. Global Cancer/Tumor Profiling Market by Melanoma Cancer, 2022 - 2030 (USD Billion)
- 23. Global Cancer/Tumor Profiling Market by Others, 2022 - 2030 (USD Billion)
- 24. Global Cancer/Tumor Profiling Market share by Biomarker Type, 2022 and 2030 (USD Billion)
- 25. Global Cancer/Tumor Profiling Market by Genomic Biomarker, 2022 - 2030 (USD Billion)
- 26. Global Cancer/Tumor Profiling Market by Protein Biomarker, 2022 - 2030 (USD Billion)
- 27. Global Cancer/Tumor Profiling Market by Others, 2022 - 2030 (USD Billion)
- 28. Global Cancer/Tumor Profiling Market share by Application, 2022 and 2030 (USD Billion)
- 29. Global Cancer/Tumor Profiling Market by Research, 2022 - 2030 (USD Billion)
- 30. Global Cancer/Tumor Profiling Market by Clinical, 2022 - 2030 (USD Billion)
- 31. Global Cancer/Tumor Profiling Market share, by Region, 2022 and 2030
- 32. North America Cancer/Tumor Profiling Market, 2022 - 2030 (USD Billion)
- 33. Europe Cancer/Tumor Profiling Market, 2022 - 2030 (USD Billion)
- 34. Asia Pacific Cancer/Tumor Profiling Market, 2022 - 2030 (USD Billion)
- 35. Latin America Cancer/Tumor Profiling Market, 2022 - 2030 (USD Billion)
- 36. The Middle-East and Africa Cancer/Tumor Profiling Market, 2022 - 2030 (USD Billion)
Table Of Tables
- 1. Global Cancer/Tumor Profiling Market: Snapshot
- 2. Drivers of the Cancer/Tumor Profiling Market: impact analysis
- 3. North America Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
- 4. North America Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
- 5. North America Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
- 6. North America Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
- 7. U.S. Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
- 8. U.S. Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
- 9. U.S. Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
- 10. U.S. Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
- 11. Canada Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
- 12. Canada Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
- 13. Canada Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
- 14. Canada Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
- 15. Europe Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
- 16. Europe Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
- 17. Europe Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
- 18. Europe Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
- 19. Germany Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
- 20. Germany Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
- 21. Germany Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
- 22. Germany Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
- 23. France Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
- 24. France Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
- 25. France Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
- 26. France Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
- 27. U.K. Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
- 28. U.K. Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
- 29. U.K. Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
- 30. U.K. Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
- 31. Italy Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
- 32. Italy Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
- 33. Italy Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
- 34. Italy Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
- 35. Spain Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
- 36. Spain Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
- 37. Spain Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
- 38. Spain Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
- 39. Rest of Europe Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
- 40. Rest of Europe Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
- 41. Rest of Europe Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
- 42. Rest of Europe Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
- 43. Asia Pacific Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
- 44. Asia Pacific Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
- 45. Asia Pacific Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
- 46. Asia Pacific Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
- 47. China Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
- 48. China Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
- 49. China Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
- 50. China Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
- 51. Japan Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
- 52. Japan Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
- 53. Japan Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
- 54. Japan Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
- 55. India Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
- 56. India Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
- 57. India Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
- 58. India Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
- 59. South Korea Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
- 60. South Korea Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
- 61. South Korea Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
- 62. South Korea Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
- 63. South-East Asia Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
- 64. South-East Asia Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
- 65. South-East Asia Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
- 66. South-East Asia Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
- 67. Rest of Asia Pacific Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
- 68. Rest of Asia Pacific Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
- 69. Rest of Asia Pacific Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
- 70. Rest of Asia Pacific Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
- 71. Latin America Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
- 72. Latin America Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
- 73. Latin America Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
- 74. Latin America Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
- 75. Brazil Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
- 76. Brazil Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
- 77. Brazil Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
- 78. Brazil Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
- 79. Mexico Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
- 80. Mexico Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
- 81. Mexico Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
- 82. Mexico Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
- 83. Rest of Latin America Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
- 84. Rest of Latin America Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
- 85. Rest of Latin America Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
- 86. Rest of Latin America Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
- 87. The Middle-East and Africa Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
- 88. The Middle-East and Africa Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
- 89. The Middle-East and Africa Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
- 90. The Middle-East and Africa Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
- 91. GCC Countries Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
- 92. GCC Countries Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
- 93. GCC Countries Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
- 94. GCC Countries Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
- 95. South Africa Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
- 96. South Africa Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
- 97. South Africa Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
- 98. South Africa Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
- 99. Rest of Middle-East Africa Cancer/Tumor Profiling Market revenue, By Technology, 2022 - 2030 (USD Billion)
- 100. Rest of Middle-East Africa Cancer/Tumor Profiling Market revenue, By Cancer Type, 2022 - 2030 (USD Billion)
- 101. Rest of Middle-East Africa Cancer/Tumor Profiling Market revenue, By Biomarker Type, 2022 - 2030 (USD Billion)
- 102. Rest of Middle-East Africa Cancer/Tumor Profiling Market revenue, By Application, 2022 - 2030 (USD Billion)
Methodology
FrequentlyAsked Questions
Cancer/Tumor profiling is a laboratory test that analyzes a tumor’s genetic, molecular, and cellular characteristics to identify specific mutations or biomarkers. This helps doctors choose the most effective, personalized treatment for a patient's cancer.
The Global cancer/tumor profiling market is expected to grow due to growing demand for personalized medicine, advancements in genomic sequencing technologies, and the rising prevalence of cancer worldwide.
According to a study, the Global cancer/tumor profiling market size was worth around USD 9.86 Billion in 2024 and is expected to reach USD 26.18 Billion by 2034.
The Global cancer/tumor profiling market is expected to grow at a CAGR of 10.4% during the forecast period.
Leading players in the Global cancer/tumor profiling market include QIAGEN, Illumina Inc., NeoGenomics Laboratories Inc., Genomic Health Inc., HTG Molecular Diagnostics Inc., Caris Life Sciences, Helomics Corporation, NanoString Technologies Inc., Sysmex Corporation, Ribomed Biotechnologies Inc., Guardant Health Inc., Foundation Medicine, Roche Diagnostics, GenScript Biotech Corporation, Tempus Labs, Boreal Genomics Inc, Perthera, Agendia, Omniseq, and Histogene X, among others., among others.
The report explores crucial aspects of the cancer/tumor profiling market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients
